CENPA and breast cancer: demonstrated that the MBNL1-AS1/ZFP36/CENPA axis downregulates CENPA expression by reducing mRNA stability, thereby inhibiting proliferation and cancer stem-like properties in BC cells, suggesting that CENPs may serve as promising therapeutic targets (21, 22).